INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS

Ozturk S., Kant A., Comoglu S., Ertunc B., YILMAZ G.

ACTA MEDICA MEDITERRANEA, cilt.37, sa.5, ss.2593-2597, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 5
  • Basım Tarihi: 2021
  • Doi Numarası: 10.19193/0393-6384_2021_5_400
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Sayfa Sayıları: ss.2593-2597
  • Anahtar Kelimeler: COVID-19, SARS-CoV-2, Immunocompromise, Hematological malignancies, Clinical Course, Severity
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Introduction: Immunocompromised patients, SARS-CoV-2 infection might have a more severe course and may cause pneumonia quicker, compared to normal hosts. The presence of comorbid diseases increases this risk even further. In our study, we aimed to determine the clinical course and severity of COVID-19 in immunocompromised patients.